Supervisory Board

We have at our disposal a highly qualified and experienced Supervisory Board which is composed of the following members:

Prof. Dr. Eric-Paul Pâques

Chairman of the Board 

Prof. Pâques is presently CEO and Chairman of the Corporate Executive Board of Grünenthal, an international research-based pharmaceutical company headquartered in Aachen, Germany. Prior to his 20 plus years at Grünenthal, he worked as the Head of Research at Behringwerke AG, in Germany. Prof. Pâques received a doctorate in Chemistry from the Université Catholique de Louvain.

Dave Lemus

Member of the Board  

Mr. Lemus most recently served as a Member of the Management Board, Executive Vice President and Chief Financial Officer of MorphoSys AG. Prior to this position, he served at F.Hoffmann-La Roche as a Controller and Operations Manager with responsibility for 90 pharma markets, and as a Treasurer of Lindt & Sprungli in Zurich, Switzerland and worked in treasury management at Electrolux AB. Mr. Lemus is a Certified Public Accountant in the U.S.A. and holds a M.S. from the MIT Sloan School of Management.

Dr. Berthold Hinzen

Member of the Board

After studying Chemistry Dr. Hinzen joined Bayer AG, where he worked in a variety of capacities in chemical drug development and marketing. Today he is the Head of a Business Development and Licensing Group, one of four business units of Bayer-Schering Pharma, Berlin, Germany; he is responsible for the cardiovascular system segment (incl. Cardiology) as well as Anti-Infections, Diabetes, Urology and Pulmonology.